Cerus Corporation

NASDAQ:CERS

Medical - Devices

Healthcare
$1.94 +2.92%

+$0.08 today

Market cap
$391.79M
Beta
1.77
P/E (TTM)
-53.8
EPS (TTM)
-$0.05
52W Low $1.15High $3.15

Volume 6.09M

Average 2.33M

CERS Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Cerus CorporationNASDAQ: CERS

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 57.0%

Gross margin was 57.0% in Q1 FY2026, down 1.8 pp from a year earlier. On a trailing-twelve-month basis it was 54.3%, down 1.7 pp year over year. Over 3 fiscal years it narrowed by 0.2 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.0%+5.5 pp QoQ
Last fiscal yearDec 2025
53.5%-1.7 pp YoY
LTMMar 2026
54.3%-1.7 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.8 pp——
1 year-1.7 pp——
3 years-0.2 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
53.5%
Year-over-year change
-1.7pp

Gross Margin vs competitors

How CERS compares with its peers on the latest reported figures

  • CERS's LTM Mar 2026 gross margin of 54.3% is the 3rd highest of the 4 companies compared; the peer median is 57.4%.
  • Its year-over-year change of -1.7 pp is the 3rd highest of 4, against a peer median of +0.6 pp.
  • Over three fiscal years its change of -0.2 pp compares with a peer median of +2.4 pp.
CERS Competitors Peer median
Gross Margin for CERS and competitors
Company Period LTM level YoY 3-year change
ADMAADMA Biologics, Inc.LTM Jun 202664.7% +11.7 pp+34.5 pp
HAEHaemonetics CorporationLTM Jun 202657.4% +0.6 pp+2.4 pp
CERSCerus CorporationLTM Mar 202654.3% -1.7 pp-0.2 pp
GRFSGrifols, S.A.LTM Jun 202637.2% -2.3 pp-0.8 pp
Peer median (excluding CERS) 57.4%+0.6 pp+2.4 pp

Competitors are the stored peer set for CERS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue130.86M162.05M156.37M180.27M206.13M
Cost of Revenue63.48M74.95M69.97M80.75M95.85M
Gross Profit67.38M87.09M86.4M99.52M110.29M
Gross Margin51.5%53.7%55.3%55.2%53.5%
Research & Development63.69M64.11M67.64M58.91M65.72M
Selling, General & Admin81.29M83.34M75.52M75.89M80.91M
Operating Expenses116.32M121.18M116.45M113.75M146.63M
Depreciation & Amortization3.15M2.98M2.6M1.86M2M
EBITDA(45.99M)(33.52M)(26.34M)(10.02M)(4.94M)
EBITDA Margin-35.1%-20.7%-16.8%-5.6%-2.4%
Operating Income(48.94M)(34.08M)(30.05M)(14.23M)(36.35M)
Operating Margin-37.4%-21.0%-19.2%-7.9%-17.6%
Interest Income00000
Interest Expense4.92M5.83M8.39M8.88M8.34M
Other Income / Expenses(5.12M)(8.26M)(7.27M)(6.53M)21.06M
Income Before Tax(54.06M)(42.34M)(37.32M)(20.76M)(15.28M)
Pre-Tax Margin-41.3%-26.1%-23.9%-11.5%-7.4%
Income Tax Expense319K488K325K205K354K
Net Income(54.37M)(42.78M)(37.49M)(20.92M)(15.63M)
Net Margin-41.6%-26.4%-24.0%-11.6%-7.6%
EPS (Basic)(0.32)(0.24)(0.21)(0.11)(0.08)
EPS (Diluted)(0.32)(0.24)(0.21)(0.11)(0.08)
Weighted Avg Shares171.28M176.55M180.27M184.56M190.59M
Weighted Avg Shares (Diluted)171.28M176.55M180.27M184.56M190.59M

Cerus Corporation

NASDAQ:CERS

Intrinsic Alpha fair value

Locked

Current Price

$1.94

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.